RETaliation-Tackling Rare Resistance Alterations to Osimertinib. Krebs MG, Popat S. Clin Cancer Res 2023;29:2951-2953.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Krebs MG, Popat S. RETaliation-Tackling Rare Resistance Alterations to Osimertinib. Clin Cancer Res 2023;29:2951-2953.
PMID: 37314773